Pacific Biosciences Of California | PACB - Beneficio Bruto En Ventas

Precio De Mercado
1.40
Cambio Diario
0.01 0.36%
Mensual
-14.42%
Anual
6.49%
Q1 Expectativa
1.29




Beneficio Bruto En Ventas Cambio Fecha
Agilent USD 946M 44M 2025-12
Bruker USD 449.2M 69.8M 2025-12
Danaher USD 3.97B 443M 2025-12
General Electric Aerospace USD 3.8B 118M 2025-12
Illumina USD 759M 26M 2025-12
Myriad Genetics USD 146.8M 3M 2025-12
Pacific Biosciences Of California USD 15.74M 601K 2025-12
Quidel USD 274.8M 1.01B 2025-12
Revvity USD 421.66M 47.06M 2025-12
Roche Holding CHF 22.09B 10.04B 2025-12
Standard Biotools USD 11.38M 1.9M 2025-12
Thermo Fisher Scientific USD 4.64B 419M 2025-12
Waters USD 557.42M 97.44M 2025-12